Stenocare
Stenocare · page 3
- Companies
Danish Medical Cannabis Company Stenocare Announces Swathe Of Updates As It Seeks Fresh Funding
DANISH medical cannabis operator Stenocare has published a flurry of operational updates over the past month as it hopes to raise up to DKK30m in a new rights issue.
- Press releases
Stenocare To Launch Medical Cannabis Oils In Germany In Coming Months
The new Stenocare medical cannabis oil product has received approval from the Federal Institute for Drugs and Medical Devices (BfArM) for prescription-based sales to German patients.
- Markets & Stocks
European Cannabis Stocks Review: Stenocare Sales Double, CannAssure To De-list From Stock Exchange & More From SEED Innovations
Stenocare This week the Danish medical cannabis company unveiled its unaudited Q4 and full year results, seeing sales more than double while losses remained flat.
- Adult-Use
What’s In Store For The European Cannabis Industry In 2023? (Part 1)
Following a milestone year for European cannabis in 2021, which saw many companies take advantage of a wave of excitement surrounding the young industry’s potential, 2022 saw this wave break sooner than many expected. 2023 is expected to bring yet more change.
- Markets & Stocks
European Cannabis Stocks Review: InterCure Up 10% Amid More Record Results, Stenocare Secures New Funding, & More From Goodbody Health
InterCure InterCure saw its stock jump nearly 10% after releasing its third quarter financial results on Tuesday, November 15.
- Adult-Use
European Cannabis Stocks Review: Stenocare Becomes Sole Supplier Of Cannabis Oil To Denmark (Again), MGC Fast Tracks Delivery Due To High Demand, & More From Love Hemp
SIGNIFICANT developments from Germany this week helped add to the momentum of interest in cannabis stocks initially driven by President Joe Biden’s recent announcements.
- Markets & Stocks
European Cannabis Stocks Review: Love Hemp Announces ‘Cessation’ Of LSE Listing Process, More From Cellular Goods & Stenocare
Love Hemp Love Hemp, which has had its shares suspended from trading on the Aquis Stock Exchange (AQSE) since May this year, announced to investors this week that its application to be listed on the Standard Segment of the London Stock Exchange has now also ‘lapsed’.
- Press releases
Stenocare Enters Its 4th Market Starting Sales In Australia In Q4 2022
AFTER securing market access and approvals in both Denmark, Sweden and UK, STENOCARE A/S (“Stenocare”) now takes a first and firm footstep into the southern hemisphere entering Australia.
- News
Stenocare Plans To Get ‘Even More Aggressive’ In Expansion Ambitions As Stock Price Jumps Double Digits
STENOCARE has seen double digit price rises across both the Copenhagen NASDAQ and the Frankfurt Stock Exchange, jumping 17.5% and 10% respectively over the past week.
- Markets & Stocks
EU Cannabis Stocks Review: Stenocare Enters UK, Cellular Goods’ Sales Disappoint & Ukraine Crisis Hammers Stocks
The tragic developments in Ukraine hit global markets hard last week, and cannabis stocks even harder.
- Press releases
STENOCARE enters the UK market with three medical cannabis oil products
STENOCARE A/S (“STENOCARE”) to make medical cannabis oil products available for UK patients.
- Medical
Boost For Danish Medical Cannabis Patients Following Canntrust Scandal
FOLLOWING a two-and-half-year break oil products have returned to the Danish medical cannabis access programme in a move which is likely to provide a boost to the faltering scheme.
